Chione Ltd 13D and 13G filings for Karyopharm Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 3:41 pm Sale |
2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Chione Ltd | 293,333 3.900% |
-40,000 (-12.00%) |
Filing |
| 2022-02-11 2:54 pm Sale |
2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Chione Ltd | 333,333 6.600% |
-33,333 (-9.09%) |
Filing |
| 2021-02-16 4:03 pm Sale |
2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Chione Ltd | 366,667 7.500% |
-13,033 (-3.43%) |
Filing |